4:41 PM
 | 
Jul 07, 2014
 |  BC Extra  |  Company News

Gruenenthal submits Zalviso MAA

Gruenenthal Group (Aachen, Germany) submitted an MAA to EMA for Zalviso to treat moderate to severe acute pain in adults in...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >